MORESCO, ROSA MARIA
 Distribuzione geografica
Continente #
AS - Asia 3.255
NA - Nord America 2.589
EU - Europa 771
SA - Sud America 510
Continente sconosciuto - Info sul continente non disponibili 118
AF - Africa 61
OC - Oceania 8
Totale 7.312
Nazione #
US - Stati Uniti d'America 2.463
SG - Singapore 1.362
CN - Cina 697
BR - Brasile 387
HK - Hong Kong 365
VN - Vietnam 275
IT - Italia 260
FR - Francia 179
BD - Bangladesh 132
KR - Corea 110
JP - Giappone 81
GB - Regno Unito 68
CA - Canada 61
IN - India 58
NL - Olanda 56
AR - Argentina 43
DE - Germania 40
FI - Finlandia 37
CO - Colombia 24
EC - Ecuador 22
MX - Messico 21
ID - Indonesia 20
TR - Turchia 19
AT - Austria 18
ZA - Sudafrica 17
IQ - Iraq 15
PH - Filippine 15
SA - Arabia Saudita 15
IL - Israele 14
VE - Venezuela 14
ES - Italia 13
PL - Polonia 13
UA - Ucraina 13
CR - Costa Rica 11
EG - Egitto 11
MY - Malesia 10
MA - Marocco 9
AU - Australia 8
CH - Svizzera 8
SE - Svezia 8
UZ - Uzbekistan 8
IR - Iran 7
KE - Kenya 7
PK - Pakistan 7
TH - Thailandia 7
EE - Estonia 6
CL - Cile 5
JM - Giamaica 5
JO - Giordania 5
NP - Nepal 5
OM - Oman 5
PE - Perù 5
RU - Federazione Russa 5
TN - Tunisia 5
BO - Bolivia 4
DK - Danimarca 4
HN - Honduras 4
IE - Irlanda 4
MD - Moldavia 4
NI - Nicaragua 4
PY - Paraguay 4
TT - Trinidad e Tobago 4
AZ - Azerbaigian 3
BY - Bielorussia 3
HR - Croazia 3
HU - Ungheria 3
KZ - Kazakistan 3
LT - Lituania 3
LV - Lettonia 3
PS - Palestinian Territory 3
RO - Romania 3
RS - Serbia 3
SV - El Salvador 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
CY - Cipro 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
GR - Grecia 2
GT - Guatemala 2
MM - Myanmar 2
PR - Porto Rico 2
SC - Seychelles 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
UY - Uruguay 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BE - Belgio 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BS - Bahamas 1
CG - Congo 1
DM - Dominica 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GD - Grenada 1
GP - Guadalupe 1
Totale 7.180
Città #
Santa Clara 846
Singapore 766
Hong Kong 354
Hefei 253
San Jose 227
Beijing 188
Ashburn 164
Los Angeles 143
Lauterbourg 136
Dallas 108
Seoul 108
Ho Chi Minh City 87
Hanoi 64
Tokyo 63
New York 56
Milan 53
Buffalo 35
São Paulo 31
Council Bluffs 26
Rome 23
Guangzhou 21
Chicago 19
Da Nang 19
Frankfurt am Main 18
Helsinki 18
Lappeenranta 18
Rio de Janeiro 17
Toronto 15
Phoenix 14
Montreal 13
Quito 13
Atlanta 12
Haiphong 12
Johannesburg 12
Newark 12
Orem 12
Houston 11
London 11
Manchester 11
Minamishinagawa 11
Naples 11
Warsaw 11
Paris 10
San José 10
Bologna 9
Brooklyn 9
Chennai 9
Amsterdam 8
Belo Horizonte 8
Brasília 8
Fortaleza 8
Istanbul 8
Jeddah 8
Miami 8
New Delhi 8
Palermo 8
Philadelphia 8
Tashkent 8
Vienna 8
Bengaluru 7
Cairo 7
Düsseldorf 7
Falkenstein 7
Mumbai 7
Piscataway 7
Shanghai 7
Stockholm 7
Sydney 7
Cagliari 6
Cesano Boscone 6
City of London 6
Denver 6
Goiânia 6
Nairobi 6
Poplar 6
Queens 6
The Bronx 6
Amman 5
Baghdad 5
Biên Hòa 5
Bogotá 5
Boston 5
Catania 5
Charlotte 5
Curitiba 5
Detroit 5
Guayaquil 5
Las Vegas 5
Mexico City 5
Seattle 5
The Dalles 5
Thái Bình 5
Turin 5
Baltimore 4
Buenos Aires 4
Cebu City 4
Chisinau 4
Desio 4
Dhaka 4
Dublin 4
Totale 4.410
Nome #
Development of a new toolbox for mouse PET-CT brain image analysis fully based on CT images and validation in a PD mouse model 103
Time course of metabolic activity and cellular infiltration in a murine model of acid-induced lung injury. 91
Positive relation between dopamine neuron degeneration and metabolic connectivity disruption in the MPTP plus probenecid mouse model of Parkinson's disease 89
[F-18]FDG and [C-11]Choline PET for the assessment of cancer development and progression in preclinical mouse models of hormone-dependent and independent prostate cancer 87
[F-18]FDG and [C-11]Choline PET evaluation of a Xenograft model of prostate cancer 81
Multimodal hypoxia imaging in a preclinical glioma model 80
Statistical voxel-based analysis of [F-18]FDG PET animal studies for the estimation of glucose metabolism in stress conditions 80
Automated radiosynthesis and preclinical evaluation of two new PSMA-617 derivatives radiolabelled via [18F]AlF2+ method 79
99mTc-Radiolabeled Silica Nanocarriers for Targeted Detection and Treatment of HER2-Positive Breast Cancer 77
Effects of Metformin as Add-On Therapy against Glioblastoma: An Old Medicine for Novel Oncology Therapeutics 76
New orphan disease therapies from the proteome of industrial plasma processing waste- a treatment for aceruloplasminemia 76
Development of [methoxy-11C]RN5 as a potential radioligand for the in vivo PET measurement of myocardial alpha1A-adrenoceptors 73
Neurochemistry of personality traits: a [18F]FESP PET study 72
In vivo imaging of adenosine A2a receptors in rat and primate brain using [11C]SCH442416. 71
An optimized semiautomatic method for labelling of palmitic acid with ( 11C)CO2 70
Exploring the neuroprotective effects of montelukast on brain inflammation and metabolism in a rat model of quinolinic acid-induced striatal neurotoxicity 70
THE IMPACT OF CARDIAC ARREST ON REGIONAL CEREBRAL GLUCOSE METABOLISM IN RATS 69
Synthesis, labeling, and biological evaluation of halogenated 2 quinolinecarboxamides as potential radioligands for the visualization of peripheral benzodiazepine receptors 67
Comparison of 18F-Fluoroazomycin-Arabinofuranoside and 64Cu-Diacetyl-Bis(N4-Methylthiosemicarbazone) in Preclinical Models of Cancer 66
A stapled chromogranin A-derived peptide homes in on tumors that express αvβ6 or αvβ8 integrins 66
Molecular and Cellular Complexity of Glioma. Focus on Tumour Microenvironment and the Use of Molecular and Imaging Biomarkers to Overcome Treatment Resistance 65
Metformin and Temozolomide, a synergic option to overcome resistance in glioblastoma multiforme models 63
Automated fluorine-18 radiolabeling via an alkyne–azide cycloaddition reaction on a dual peptide-functionalized liposome surface for in vivo PET imaging 63
Imaging Metformin Efficacy as Add-On Therapy in Cells and Mouse Models of Human EGFR Glioblastoma 62
Radio-chemotherapy and metformin selectively modulate the heterogeneous landscape of glioma with ribosome biogenesis, long non coding RNA and immune-escape markers as major player 61
Glucose metabolism and serotonin receptors in the frontotemporal lobe degeneration 61
Microglial activation in Parkinson's disease and Lewy body dementia: A PET study 61
Synthesis and biological characterization of novel 2-quinolinecarboxamide ligands of the peripheral benzodiazepine receptors bearing technetium-99m or rhenium. 60
Evaluation of Radiotherapy associated with Temozolomide plus Metformin in a GBM immunocompetent microenvironment 60
Stem Cell-Derived Human Striatal Progenitors Innervate Striatal Targets and Alleviate Sensorimotor Deficit in a Rat Model of Huntington Disease. 59
Imaging temozolomide-induced changes in the myeloid glioma microenvironment 59
Validation of an Engineered Cell Model for In Vitro and In Vivo HIF-1? Evaluation by Different Imaging Modalities 59
Translation Imaging in Parkinson's Disease: Focus on Neuroinflammation 58
Disruption of redox homeostasis for combinatorial drug efficacy in K-Ras tumors as revealed by metabolic connectivity profiling 58
Aberrant L-Fucose Accumulation and Increased Core Fucosylation Are Metabolic Liabilities in Mesenchymal Glioblastoma 58
Influence of glycolytic phenotype on anti-angiogenic therapy response in ovarian cancer xenograft models evaluated by PET imaging 58
Molecular imaging applied on hypoxia evaluation: comparison of BLI, FLI and PET imaging 58
Therapeutic antibody targeting of Notch1 in T-acute lymphoblastic leukemia xenografts. 57
In vivo evaluation of mu-opioid receptors in obesity: a PET study. 57
In vivo susceptibility to energy failure parkinsonism and LRRK2 kinase activity 57
Cancer cell growth and survival as a system-level property sustained by enhanced glycolysis and mitochondrial metabolic remodeling. 57
The driving role of the Cdk5/Tln1/FAK S732 axis in cancer cell extravasation dissected by human vascularized microfluidic models 57
Peptide-mimetics derived from leucyl-tRNA synthetase are potential agents for the therapy of mt-tRNA related diseases 56
Validation of a new combretastatin A-4 (CA-4) analogue in a colon cancer mouse model using PET imaging 56
In vivo PET monitoring of an experimental model of peritoneal carcinogenesis 55
MONITORING PRECLINICAL MODEL OF BREAST CANCER WITH [18F]FLT AND [18F]FDG-PET 55
Assessing glutamine cancer metabolic remodelling in an animal model using PET imaging 55
Role of Metformin and AKT Axis Modulation in the Reversion of Hypoxia Induced TMZ-Resistance in Glioma Cells Alessia Lo Dico1,2+, Silvia Valtorta2,3,4+, Luisa Ottobrini 1,2? and Rosa Maria Moresco2,3,4*? 1 55
In vivo microglia activation in very early dementia with Lewy bodies, comparison with Parkinson's disease 54
Evaluation of three quinoline-carboxamide derivatives as potential radioligands for the in vivo pet imaging of neurodegeneration 54
Exploring The Neuroprotective Effects Of Montelukast Treatment In A Rat Model Of Quinolinic Acid-Induced Neurotoxicity 54
In vivo evaluation of mu opioid receptors in obesity: a PET in vivo 54
18F-VC701-PET and MRI in the in vivo neuroinflammation assessment of a mouse model of multiple sclerosis. 54
A voxel-based PET study of dopamine transporters in Parkinson's disease: relevance of age at onset. 54
Early but different PET cholinergic impairment in AD and DLB and correlations with long term memory scores 53
Role of TREM-2 in neurodegenerative disorders of the central nervous system 53
In vivo PET study of 5HT(2A) serotonin and D(2) dopamine dysfunction in drug-naive obsessive-compulsive disorder. 53
Comparison of parametric imaging methods for [11C]MP4A PET: A simulation based study 53
Central GABAergic dysfunction in primary dystonia 53
Ibuprofen plus Isosorbide Dinitrate treatment in the mdx mice ameliorates dystrophic heart structure 53
The status of dopamine nerve terminal in Parkinson s disease and essential tremor: A PET study with the tracer [11-C]FE-CIT 52
Longitudinal evaluation of tissue hypoxia and glucose metabolism in different preclinical models of cancer 52
The peritumoral brain zone in glioblastoma: where we are and where we are going 52
Evaluating [18F]FDG and [18F]FLT Radiotracers as Biomarkers of Response for Combined Therapy Outcome in Triple-Negative and Estrogen-Receptor-Positive Breast Cancer Models 51
MAP vs RLS methods for [11C]MP4A PET pixel-wise quantification in neurodegenerative diseases discrimination 51
[(11)C]-MP4A PET cholinergic measurements in amnestic mild cognitive impairment, probable Alzheimer's disease, and dementia with Lewy bodies: a Bayesian method and voxel-based analysis 51
[18F](2S,4R)-4-Fluoroglutamine as a New Positron Emission Tomography Tracer in Myeloma 51
statistical parametric mapping for activations studies in rats 50
In-vivo PET characterization of lung cancer tumorgraft models 50
Frontiers in Anti-Cancer Drug Discovery: Challenges and Perspectives of Metformin as Anti-Angiogenic Add-On Therapy in Glioblastoma 50
Exploring Translocator Protein (TSPO) Medicinal Chemistry: An Approach for Targeting Radionuclides and Boron Atoms to Mitochondria 49
Fluvoxamine treatment and D(2) receptors: a PET study on OCD drug-naive patients 49
Microglial activation in Parkinson's disease and Lewy Body Dementia: PET studies and proteomic analysis 49
NSCR_Dataset 49
Synthesis and carbon-11 labeling of (R)- and (S)-thionisoxetine, norepinephrine reuptake inhibitors, potential radioligands for positron emission tomography. 48
Assessing cancer metabolic remodeling in animal models using PET imaging 47
Study of the Tissue Distribution of TLQP-21 in Mice Using [18F]JMV5763, a Radiolabeled Analog Prepared via [18F]Aluminum Fluoride Chelation Chemistry 47
Statistical voxel-based analysis of [18F]FDG PET animal studies for the estimation of glucose metabolism in stress conditions 47
Monitoring disease evolution and treatment response in lysosomal disorders by the peripheral benzodiazepine receptor ligand PK11195. 46
Autoradiographic and small-animal pet comparisons between [18fFfaza and [64Cu]ATSM in EMT-6, fadu and PC-3 xenograft tumor models 46
New Brain Atlas tool for Parkinson's Disease Images Analysis 46
Adenosine A2A receptors and basal ganglia physiology. 46
[18F]FDG and [18F]FLT PET for the evaluation of response to neo-adjuvant chemotherapy in a model of triple negative breast cancer 46
Evaluation of response to therapy in ovarian cancer models with different glycolytic phenotype using in-vivo imaging PET 45
Quinolinic acid induced neurodegeneration in the striatum: a combined in vivo and in vitro analysis of receptor changes and microglia activation. 45
MAP method for [11C]MP4A PET pixel wise quantification: a comparative study in aMCI, pAD and LBD 44
Validation of SPM for the automatic analysis of [11C]FE-CIT: PET images in patients with movement disorders. 44
The evaluation of [18F]FDG and [18F]FLT radiotracers as potential biomarkers of early treatment outcome in triple negative breast cancer (TNBC) 44
Radiosynthesis and preliminary biological evaluation of [18F]VC701, antagonist of PBR receptor, potentially useful for the study of neurodegenerative diseases 43
MI in Cancer Biology Visualisation of Extra- and Intracellular Processes PET and MRI studies applied on characterization of Fisher/F98 rat glioma model 43
[C-11]radiosynthesis of Thionisoxetine, potential radioligand for PET imaging in vivo in the norepinephrine transpoter 43
VEGF-targeted therapy stably modulates the glycolytic phenotype of tumor cells 43
PET evidence of central GABAergic changes in stiff-person syndrome. 42
Acute stress studies in rats by 18FDG PET and SPM 42
VEGF targeted therapy stably modulates the glycolytic phenotype of tumor cells. 42
Radiosynthesis and Preliminary Biological Evaluation of [18F]VC701, a Radioligand for Translocator Protein 42
Progression of Parkinson's disease in patients with early and late onset disease: a PET study with [11C]Fe-CIT 42
Effect of fluvoxamine on cortical 5HT2A receptors assessed dy PET and (11C) MDL100907 in drug naive obsessive compulsive patients 42
In vitro evaluation of mu-opioid receptors in obesity: a PET study 41
Characterization of a rat glioma model with MR, [18F]FAZA- and [18F]FDG-PET imaging 41
Totale 5.678
Categoria #
all - tutte 24.828
article - articoli 17.595
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 109
Totale 42.532


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202449 0 0 0 0 0 0 0 0 0 0 45 4
2024/20252.667 8 10 206 82 718 172 52 178 116 109 542 474
2025/20263.888 188 325 295 546 741 200 534 146 202 279 246 186
2026/2027708 192 197 319 0 0 0 0 0 0 0 0 0
Totale 7.312